Tony Listro interviewed in Drug Development & Delivery
Don’t miss the interview with our Vice President of Technology and Site Lead for SPS’s North American site, Tony Listro, in the September issue of Drug Development & Delivery. Among other things, he explains why Sever Pharma Solutions emphasizes our ability to handle HPAPIs in polymer-based dosage forms and how he sees the polymers market and the CDMO segment shaping up in 2023.
Drug Development & Delivery, including its exclusive Specialty Pharma section, is a print publication, conference organizer (Drug Development Networking Summit), and online content provider exclusively committed to advancing the applied science, technology, and related business practices of pharmaceutical and biological drug development.
